Home Pathos AI

Pathos AI

In operation
Series D
Biotechnology Developer

Basic Information

Pathos AI is a clinical-stage biotechnology company focused on redesigning drug development. By leveraging artificial intelligence technologies, multimodal real-world data, and patient-derived biological models, Pathos advances precision medicines to market through collaborations with biopharmaceutical companies.
Pathos AI, Inc.
Chicago,Illinois,United States of America
less than 15 people
January 01, 2020
contact@pathos.com